Giant cell arteritis (GCA) is a serious disease and the most common cause of vasculitis in the elderly. Here, studies describing the recent discovery of varicella zoster virus (VZV) in the temporal arteries of patients with GCA are reviewed.
INTRODUCTION
Varicella zoster virus (VZV) is an exclusively human neurotropic alphaherpesvirus. Primary VZV infection causes varicella (chickenpox), after which virus becomes latent in ganglionic neurons along the entire neuraxis. Decades later, as VZV-specific cellmediated immunity wanes, virus reactivates, resulting in zoster (pain and rash restricted to one or two dermatomes). Unfortunately, the pain of zoster may persist for months or years (postherpetic neuralgia). Zoster may be further complicated by other serious neurological diseases such as meningoencephalitis, cerebellitis, isolated or multiple cranial nerve palsies (polyneuritis cranialis), myelitis and vasculopathy, and multiple ocular disorders. These serious conditions cause paralysis, blindness, and death. Importantly, all of the neurological and ocular disorders listed above can also develop in the absence of rash. The incidence and severity of zoster is best viewed as a continuum in immunodeficient individuals, ranging from a natural decline in VZV-specific immunity with advancing age to more serious host immune deficits encountered in organ transplant recipients and patients with cancer or AIDS.
VZV is the only human virus that has been shown to replicate in arteries and cause disease. Productive VZV infection in cerebral arteries leads to intracerebral VZV vasculopathy [1, 2] . An exciting finding in the past few years is that productive VZV infection and vascular disease is not limited to the intracranial circulation; indeed, VZV infects extracranial TAs and is closely associated with giant cell arteritis (GCA). The search for VZV in GCA was motivated by virtually identical pathological changes seen in patients with intracerebral VZV vasculopathy or with GCA. In both conditions, the disorder is characterized by granulomatous arteritis, in which inflammation, often transmural, is seen along with necrosis, usually in the arterial media; multinucleated giant cells, epithelioid macrophages, or both are also present.
The association of granulomatous arteritis with the presence of VZV in intracerebral VZV vasculopathy prompted examination of temporal artery biopsies for VZV from patients with pathologically verified GCA and from patients with clinical features and laboratory abnormalities of GCA whose temporal artery biopsies were pathologically negative for VZV.
CASE STUDIES
The story began with virological analysis of a temporal artery biopsy from an 80-year-old man who developed left ophthalmic-distribution zoster and ipsilateral ischemic optic neuropathy (ION) [3] . The temporal artery revealed inflammation, but not the more extensive pathology characteristic of GCA. VZV antigen was abundant in the arterial adventitia and scattered throughout the media of the asymptomatic temporal artery. The patient was initially treated with steroids but did not improve. After the presence of VZV was confirmed virologically, the patient was treated with intravenous acyclovir and his vision recovered. Overall, the patient was considered as having VZV-induced ION and subclinical temporal artery infection. Importantly, the location of VZV in the temporal artery suggested that virus entered arteries through nerve fibers within the adventitia and spread transmurally.
The second patient was a 75-year-old woman who developed periorbital pain and blurred vision OS. There was no history of zoster rash. Visual acuity was 20/40 OD, 20/400 OS, with a mild left relative afferent pupillary defect [4] . The left optic nerve was swollen and hyperemic with peripapillary flame hemorrhages. The erythrocyte sedimentation rate (ESR) was 124 mm/h. She was treated with intravenous methylprednisolone, 250 mg every 6h. On day 3, headache and vision improved. The erythrocyte sedimentation rate was 98 mm/h and C-reactive protein was 1.40 mg%. Rheumatoid factor, antinuclear antibody, and anti-neutrophil cytoplasmic antibody titers were negative. On day 4, left temporal artery biopsy was GCA-negative; steroids were changed to oral prednisone, 60 mg daily. On day 7, brain MRI with gadolinium was negative. On day 9, pain and vision worsened. On day 11, orbital CT and head CT angiography were negative. On day 15, visual acuity was 20/400 OS with relative left afferent papillary defect. On day 17, the OS became blind and nonreactive to light; fundus was obscured by vitreous hemorrhage. Cerebrospinal fluid (CSF) contained 8 WBCs/mm 3 , protein 72 mg%, glucose 54 mg%. CSF cultures for bacteria, fungi, acid-fast bacillus, and cytology were negative. Despite the absence of GCA pathology in the temporal artery, VZV ION was considered, and she was treated with intravenous acyclovir, 10 mg/kg every 8h for 7 days. On day 31, CSF contained anti-VZV immunoglobulin G (IgG) but not anti-herpes simplex virus (anti-HSV) IgG antibody, and serum-to-CSF ratio of anti-VZV IgG was reduced (14) compared with ratios for total IgG (121) and albumin (81). Immunohistochemistry and pathology revealed VZV antigen and neutrophils in the original left temporal artery specimen. On day 31, she was treated with oral valacyclovir, 1 g three times daily for 6 weeks; prednisone was reduced to 20 mg daily and tapered to 5 mg/week. Six weeks later, pain resolved and visual acuity improved to finger-counting. The left optic nerve was pale, with clear margins and resolution of hemorrhage. Essentially, another case of VZV ION with sublinical temporal artery infection was uncovered, this time with no history of zoster rash.
The next link of VZV vasculopathy with features of GCA was provided by a 54-year-old woman with diabetes who developed ION followed by acute
KEY POINTS
VZV is the only human virus shown to replicate in arteries and cause disease.
The pathology of intracerebral VZV vasculopathy and giant cell arteritis is characterized by granulomatous arteritis.
Productive VZV infection (herpesvirus virions, VZV antigen, and VZV DNA) is seen in intracerebral VZV vasculopathy and giant cell arteritis.
The number of temporal artery sections examined for VZV is critical.
The distribution of VZV in the temporal artery and the presence of VZV in skip areas inform pathogenesis.
The detection of VZV in some normal temporal arteries indicates subclinical VZV reactivation, not another site of VZV latency.
As VZV likely triggers the immunopathology of giant cell arteritis, antiviral treatment may confer additional benefit to corticosteroid-treated patients, although the optimal antiviral regimen remains to be determined.
retinal necrosis and multiple areas of focal venous beading [5] . The vitreous fluid contained amplifiable VZV DNA but not HSV-1, cytomegalovirus, or toxoplasma DNA. The clinical presentation was remarkable for jaw claudication and intermittent scalp pain, prompting a temporal artery biopsy that was pathologically negative for GCA but notable for the presence of VZV antigen. The case added to the clinical spectrum of multifocal VZV vasculopathy.
DETECTION OF VARICELLA ZOSTER VIRUS IN GIANT CELL ARTERITIS-POSITIVE AND GIANT CELL ARTERITIS-NEGATIVE TEMPORAL ARTERIES
Further efforts to address the incidence of VZV infection in archived GCA biopsy-negative temporal arteries from patients with clinically suspected GCA revealed VZV, but not HSV-1 antigen, in 5/24 (21%) temporal arteries of these patients [6] . Thirteen normal temporal arteries did not contain VZV or HSV-1 antigen. Interestingly, all five patients whose temporal arteries contained VZV antigen presented with clinical and laboratory features of GCA that included early visual disturbances. At that point, it was clear that multifocal VZV vasculopathy can present with the full spectrum of clinical features and laboratory abnormalities characteristic of GCA, and that in GCA-negative/VZV-positive temporal arteries, viral antigen predominated in the arterial adventitia.
During the continuing search for VZV antigen in GCA-negative temporal arteries, the temporal artery of one patient revealed abundant VZV antigen and VZV DNA in multiple regions (skip areas) spanning 350 mm, and in skeletal muscle adjacent to the infected temporal artery; pathological analysis of sections adjacent to those containing viral antigen revealed inflammation involving the arterial media and abundant multinucleated giant cells characteristic of GCA [7] . The detection of VZV followed by additional pathological studies led to a change in diagnosis for GCA-negative to classic GCA. In three other such cases, the detection of VZV in a GCA-negative temporal artery led to more extensive pathological studies and also a change in diagnosis to GCA.
RETROSPECTIVE ANALYSIS OF ARCHIVED GIANT CELL ARTERITIS-POSITIVE AND GIANT CELL ARTERITIS-NEGATIVE TEMPORAL ARTERIES FOR VARICELLA ZOSTER VIRUS
To test the hypothesis that VZV infection triggers the inflammatory cascade characteristic of GCA, formalin-fixed, paraffin-embedded GCA-positive temporal artery biopsies (50 sections/temporal artery), including adjacent skeletal muscle, and normal temporal artery biopsies from patients more than 50 years of age were examined for the presence and distribution of VZV antigen by immunohistochemistry and ultrastructurally for virions; adjacent regions were examined by hematoxylin-eosin staining. Most VZV antigen-positive slides were analyzed by PCR for VZV DNA. VZV antigen was detected in 61/82 (74%) GCA-positive temporal arteries compared with 1/13 (8%) normal temporal arteries (P < 0.0001). Most GCA-positive temporal arteries contained viral antigen in skip areas [8 && ]. VZV antigen, present mostly in the arterial adventitia followed by the media and intima, was detected in 12/32 (38%) skeletal muscles adjacent to VZV antigen-positive temporal arteries ( Fig. 1 ). Despite formalin fixation, VZV DNA was readily detected in: 18/45 (40%) GCA-positive/VZV antigen-positive temporal arteries; 6/10 (60%) VZV antigen-positive skeletal muscles; and one VZV antigen-positive normal temporal artery. Varicella zoster virions were also found in a GCA-positive temporal artery. GCA pathology in sections adjacent to those containing VZV was seen in 89% of GCA-positive temporal arteries, but in none of 18 adjacent sections from normal temporal artery. Overall, most GCApositive temporal arteries contained VZV in skip areas that correlated with adjacent GCA pathology, strongly suggesting that VZV triggers GCA immunopathology.
The detection of well-delineated herpesvirus particles by transmission and scanning electron microscopy in the same area stained with anti-VZV antibody is further evidence of VZV in GCApositive temporal arteries. Moreover, despite fixation, VZV DNA was readily amplifiable in many slides that contained VZV antigen. Together, the findings of VZV antigen, VZV DNA, and VZVs in temporal arteries indicate productive infection.
The search for VZV was extended to patients with clinically suspect GCA with histopathologically negative temporal artery biopsies, and biopsypositive and normal temporal arteries removed postmortem from age-matched patients [9 && ]. VZV antigen was found in 45/70 (64%) GCA-negative temporal arteries compared with 11/49 (22%) normal temporal arteries (P < 0.001), and extension of our earlier study revealed VZV antigen in 68/93 (73%) of GCA-positive temporal arteries compared with 11/49 (22%) normal temporal arteries (P < 0.001). Compared with the prevalence in normal temporal arteries, VZV antigen was more likely to be present in both GCA-negative temporal arteries (P < 0.001) and GCA-positive temporal arteries (P < 0.001). VZV was frequently found in perineurial cells expressing claudin-1 around nerve bundles. Of 44 GCA-negative patients whose temporal arteries contained VZV antigen, 16 (36%) showed adventitial inflammation adjacent to viral antigen; no inflammation was seen in normal temporal arteries. Together, our data suggest that the prevalence of VZV in the temporal arteries of patients with clinically suspected GCA is similar, independent of whether biopsy is negative or positive pathologically.
NUMBER OF TEMPORAL ARTERY SECTIONS EXAMINED FOR VARICELLA ZOSTER VIRUS IS CRITICAL
Success in detecting VZV in temporal arteries was largely based on immunostaining of no less than 50 sections of every temporal artery in all studies above.
PCR in earlier studies to examine fixed GCA-positive and GCA-negative temporal arteries for VZV did not reveal VZV DNA when one to six sections per temporal artery were examined [10] [11] [12] [13] , and immunohistochemistry using VZV-specific antibodies did not detect VZV antigen when only one section from each temporal artery was analyzed [10] , whereas analysis of four to six sections detected VZV DNA in 9/35 (26%) GCA-positive temporal arteries [14] , and examination of 10 sections detected VZV DNA in 18/57 (32%) specimens from GCA-positive temporal arteries and in 18/56 (32%) of GCA-negative temporal arteries [15] . Furthermore, examination of 25 sections of each formalin-fixed, paraffin-embedded temporal artery biopsy specimen revealed VZV antigen in 5/24 (21%) GCA-negative temporal arteries [6] . Overall, our detection of VZV antigen in most GCA-positive and GCA-negative TAs indicates the value of staining many sections, most likely increasing detection of virus in skip regions. Immunostaining of several hundred sections of each GCA-positive temporal artery might reveal VZV in nearly all GCA-positive arteries.
DISTRIBUTION OF VARICELLA ZOSTER VIRUS IN THE TEMPORAL ARTERY AND PRESENCE OF VARICELLA ZOSTER VIRUS IN SKIP AREAS INFORM PATHOGENESIS
The consistently greater frequency of VZV in the adventitia than in the media and intima in GCApositive and GCA-negative temporal arteries most likely reflects transaxonal transport of virus along afferent nerve fibers that innervate the temporal artery after reactivation from ganglia [16] . VZV in skip areas and almost always adjacent to pathology parallels the pathological features of GCA. The presence of VZV in skeletal muscle likely reflects the fact that the mammalian superficial temporal artery is richly innervated and that nociception in connective tissue of the temporalis muscle is relayed by afferent fibers with cell bodies in the trigeminal ganglia from which VZV reactivates. Interestingly, about 40% of patients with GCA have a history of polymyalgia rheumatica. As muscle biopsy is not usually performed in these patients, the frequency of VZV infection in peripheral skeletal muscle is unknown.
Another important finding in our studies is that the presence of VZV DNA and VZV antigen in 18% of control temporal arteries without inflammation indicates that VZV reactivates subclinically in some people over age 50. VZV DNA is found in latently infected human ganglia and VZV expression is limited to expression of late VZV gene 63 RNA [17] . If VZV were latent in temporal arteries, only VZV DNA would be found, not VZV late glycoproteins.
FUTURE OF VARICELLA ZOSTER VIRUS ANTIGEN DETECTION IN GIANT CELL ARTERITIS AND TREATMENT
As in GCA, VZV antigen and inflammation are usually patchy and detected in only some sections. Our research-focused evaluation is not practical for routine diagnostic work-up of temporal artery biopsies and although immunohistochemical evaluation is worthwhile, a negative result should still consider that a negative biopsy does not rule out GCA or VZV reactivation.
As for treatment of GCA, no trials have yet been conducted to determine whether antivirals and steroids confer additional benefit to steroids alone. Although many patients with GCA improve with steroids, reports are legion of patients with GCA who not only fail steroids, but also develop more disseminated VZV vasculopathy and die [18 & ,19 & ]. If VZV triggers the immunopathology of GCA, antiviral treatment is likely to confer additional benefit to patients with corticosteroid-treated GCA, although the optimal antiviral regimen remains to be determined. We currently treat GCA with prednisone, 1 mg/kg, along with valacyclovir, 1 g three times daily. If the patient improves after 4-6 weeks, we recommend tapering prednisone and thereafter administering antiviral reagents for another 4-6 weeks. Long-term antiviral drugs are far less risky than long-term steroids.
CONCLUSION
Virological analysis of temporal arteries from patients with pathologically verified GCA and temporal arteries from GCA-negative patients manifesting clinical and laboratory features of GCA whose temporal artery biopsies are pathologicallynegative for GCA revealed the presence of VZV in most GCA-positive and GCA-negative temporal artery biopsies, particularly in skip areas that correlate with adjacent GCA pathology. The presence of VZV in GCA-positive and GCA-negative temporal arteries reflects the possible role of VZV in triggering the immunopathology of GCA and indicates the need for treatment in both groups of patients with antiviral drugs in addition to corticosteroids. Whether oral antiviral agents and steroids are as effective as intravenous acyclovir and steroids, and the dosage and duration of treatment, remains to be determined.
